# CRISPR Therapeutics AG: Form 8-K, filed Aug 3, 2026

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: 8-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 16:24 ET
- Period: 2026-08-03
- Accession: 0001193125-26-330644
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000119312526330644/crsp-20260803.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000119312526330644/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000119312526330644/crsp-20260803.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-330644. Last ingested by Listed: Nov 14, 2026, 12:58 ET. No prices; not investment advice.
